Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Prostatic Neoplasms 11Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 8Leukemia 8Lymphoma, Non-Hodgkin 7Burkitt Lymphoma 5Hodgkin Disease 4Neoplasm Metastasis 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Biphenotypic, Acute 3Dendritic Cell Sarcoma, Interdigitating 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Multiple Myeloma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Urogenital Neoplasms 1Thymoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myasthenia Gravis 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1

Interventions

Radiotherapy 3Thymectomy 1Prednisone 1Prednisolone 1Fentanyl 1Etoposide 1Drug Therapy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Thymoma × Prednisolone × Clear all
NCT00294658 2017-05-23

Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy

University of Alabama at Birmingham

Phase 3 Completed
126 enrolled 42 charts
Thoracic

Myasthenia Gravis, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡